Lipocine Return On Equity vs. Number Of Shares Shorted

LPCN Stock  USD 4.72  0.17  3.48%   
Based on the measurements of profitability obtained from Lipocine's financial statements, Lipocine's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Lipocine's ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.80)
Current Value
(0.84)
Quarterly Volatility
86.55521757
 
Credit Downgrade
 
Yuan Drop
 
Covid
As of the 19th of November 2024, Operating Cash Flow Sales Ratio is likely to grow to 4.37, though Price To Sales Ratio is likely to grow to (4.90). At this time, Lipocine's Accumulated Other Comprehensive Income is very stable compared to the past year. As of the 19th of November 2024, Income Tax Expense is likely to grow to 792.75, while Operating Income is likely to drop (18.8 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.560.63
Fairly Down
Slightly volatile
For Lipocine profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Lipocine to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Lipocine utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Lipocine's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Lipocine over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.75)
Revenue Per Share
0.903
Quarterly Revenue Growth
137.519
Return On Assets
(0.23)
Return On Equity
(0.34)
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Lipocine Number Of Shares Shorted vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Lipocine's current stock value. Our valuation model uses many indicators to compare Lipocine value to that of its competitors to determine the firm's financial worth.
Lipocine is rated below average in return on equity category among its peers. It is rated below average in number of shares shorted category among its peers . At this time, Lipocine's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lipocine's earnings, one of the primary drivers of an investment's value.

Lipocine Number Of Shares Shorted vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Lipocine

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.34
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Lipocine

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
75.2 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Lipocine Number Of Shares Shorted Comparison

Lipocine is currently under evaluation in number of shares shorted category among its peers.

Lipocine Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Lipocine, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Lipocine will eventually generate negative long term returns. The profitability progress is the general direction of Lipocine's change in net profit over the period of time. It can combine multiple indicators of Lipocine, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income7.3 K7.6 K
Operating Income-17.9 M-18.8 M
Income Before Tax-16.4 M-17.2 M
Net Loss-16.4 M-17.2 M
Income Tax Expense 755.00  792.75 
Net Loss-16.3 M-17.1 M
Total Other Income Expense Net1.6 M1.7 M
Net Loss-12.4 M-13 M
Non Operating Income Net Other-3.4 M-3.2 M
Net Interest Income1.4 M1.4 M
Interest Income1.4 M1.4 M
Change To Netincome-340.4 K-323.4 K
Net Loss(3.10)(3.26)
Income Quality 0.73  1.10 
Net Income Per E B T 1.00  0.80 

Lipocine Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Lipocine. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Lipocine position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Lipocine's important profitability drivers and their relationship over time.

Use Lipocine in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lipocine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will appreciate offsetting losses from the drop in the long position's value.

Lipocine Pair Trading

Lipocine Pair Trading Analysis

The ability to find closely correlated positions to Lipocine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lipocine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lipocine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lipocine to buy it.
The correlation of Lipocine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipocine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipocine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lipocine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Lipocine position

In addition to having Lipocine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Food Products Thematic Idea Now

Food Products
Food Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Food Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Food Products Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out Correlation Analysis.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
To fully project Lipocine's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Lipocine at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Lipocine's income statement, its balance sheet, and the statement of cash flows.
Potential Lipocine investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Lipocine investors may work on each financial statement separately, they are all related. The changes in Lipocine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lipocine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.